Mar. Drugs 2017, 15, 352
7 of 10
(S)(+)-12-(tert-Butyldimethylsilyloxy)-2-methyldodecyl 6-methoxy-2-naphthoate (12). A solution of alcohol
1
3
(6 mg, 0.0181 mmol), 4-dimethylaminopyridine (0.54 mg, 0.44
µ
mol) and 6-methoxy-2-naphthoic
◦
acid (5 mg, 0.0247 mmol) in CH Cl (0.50 mL) was cooled to 0 C and treated with EDCI
2
2
(1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, 2.7 mg, 1.74 µmol) and the mixture was stirred at
room temperature overnight. The solvent was removed under a stream of N , and the residue was
2
separated using preparative thin layer chromatography (1:9 EtOAc/hexanes) to give ester 12 (1.12 mg,
1
1
1
1
1
3%). [α
] +1.29 (c 1.63, CHCl ). H NMR (CDCl , 500 MHz)
δ
8.52 (s, 1H), 8.04 (dd, J = 8.6, 1.8 Hz,
D
3
3
H), 7.85 (d, J = 8.6 Hz, 1H), 7.76 (d, J = 9.2 Hz, 1H), 7.20 (dd, J = 9.2, 2.6 Hz, 1H), 7.16 (d, J = 2.6 Hz,
H), 4.26 (dd, J = 10.3, 5.8 Hz, 1H), 4.15 (dd, J = 10.3, 6.9 Hz, 1H), 3.59 (t, J = 6.9 Hz, 2H), 1.63 (m, 1H),
.50 (m, 1H), 1.31–1.25 (m, 20 H), 1.05 (d, J = 6.8 Hz, 3H), 0.89 (s, 6H), 0.04 (s, 9H).
N-Benzoylimidazole (5). The method of Nakanishi and coworkers was adapted, for the preparation of
5
[
37]. A solution of benzoyl chloride (2 mL) in benzene (20 mL) was added dropwise to a solution of
◦
imidazole (2.32 g, 34.1 mmol) and benzene (200 mL). The resulting mixture was cooled to 8 C, then
allowed to warm to room temperature and stirred overnight. After removal of solvent, pure
obtained as a clear oil. The H NMR data were consistent with literature values [27].
5 was
1
0
D-(E)-(–)-erythro-N,O,O -(Tribenzoyl)sphingosine (
6
) [16]. A solution of D-erythro-sphingosine (1a, 10 mg,
0
.03 mmol) and N-benzoylimidazole (82 mg, 0.476 mmol) in acetonitrile (5 mL) was treated with DBU
◦
(49
µL, 0.33 mmol) and the mixture stirred at 70 C for 24 h, then at room temperature for 24 h. After
removal of solvent, the mixture was separated using flash chromatography (1:9 EtOAc: hexane), which
yielded perbenzoylated D-erythro-sphingosine (
6
[
16], 11.9 mg, 58% yield). [
α
]D
−
5.90 (c 2.06, CHCl3).
1
H NMR (CDCl , 400 MHz)
δ 8.02 (m, 4H), 7.74 (m, 2H), 7.58–7.39 (m, 9H), 6.73 (d, J = 8.8 Hz, 1H), 5.96
3
(dt, J = 15.5, 7.8 Hz, 1H), 5.80 (t, J = 6.5 Hz, 1H), 5.66 (dd, J = 15.4, 7.0 Hz, 1H), 4.94 (m, 1H), 4.72 (dd,
J = 11.7, 6.4 Hz, 1H), 4.60 (dd, J = 11.7, 4.3 Hz, 1H), 2.06 (q, J = 7.0 Hz, 2H), 1.35–1.21 (m, 18H), 0.88 (t,
J = 7.0 Hz, 3H).
0
D-erythro-N,O,O -(Tribenzoyl)sphinganine (
7). A mixture of
6
(5.9 mg, mmol) and 10% Pd-C (1 mg)
in ethyl acetate (0.6 mL) was stirred under an atmosphere of H at room temperature for 48 h then
2
1
filtered (syringe filter, 0.45-µm) to give
7
. The H NMR and CD spectroscopic data were consistent
with literature values [23].
0
0
0
D-(E)-erythro-N,O,O -Tri-(6 -methoxy-2 -naphthoyl)sphingosine (
(
8
). A mixture of D-erythro-sphingosine
L, 0.33 mmol), and N-(6-methoxy-2-naphthoyl)imidazole (
08 mg, 0.43 mmol) and dry acetonitrile (5 mL) was stirred overnight at room temperature, then stirred
1a, 11.6 mg, 0.039 mmol), DBU (49
µ
9,
1
◦
at 60 C for an additional 24 h. The solution was then concentrated under a stream of Ar and solvent
traces were removed under high vacuum for 30 min to give a crude product which was separated
by flash chromatography (3:7 EtOAc-hexane) followed by HPLC (silica, 10
×
25 mm column, 3:7
8.51 (s, 1H), 8.48 (s, 1H), 8.22 (s,
H), 8.02 (d, J = 8.6 Hz, 1H), 7.98 (d, J = 8.6 Hz, 1H), 7.82–7.66 (m, 6H), 7.18–7.08 (m, 6H), 6.97 (m, 2H),
.03 (dt, J = 15.6, 7.8 Hz, 1H), 5.93 (t, J = 5.3 Hz, 1H), 5.76 (dd, J = 15.4, 7.1 Hz, 1H), 5.05 (m, 1H), 4.86
−
EtOAc-hexane, 4 mL min ) to give 8. H NMR (CDCl , 400 MHz) δ
3
1
1
·
1
6
(
(
dd, J = 11.7, 5.8 Hz, 1H), 4.75 (dd, J = 11.7, 4.6 Hz, 1H), 2.09 (q, J = 7.0 Hz, 2H), 1.38–1.17 (m, 18H), 0.88
t, J = 7.0 Hz, 3H).
0
0
N-(6 -Methoxy-2 -naphthoyl)imidazole (
9). The method of Nakanishi and coworkers was adapted for
the preparation of 38]. A solution of 6-methoxy-2-naphthoyl chloride (147 mg, 0.668 mmol) in
9
[
toluene (1.5 mL) was added to a suspension of imidazole (91.1 mg, 1.34 mmol) in toluene (5 mL)
and the mixture stirred at room temperature overnight. The mixture was filtered through Celite,
and the filter bed washed with additional toluene. After removal of solvent from the combined
filtrates under reduced pressure, a clear glass of N-(6-methoxy-2-naphthoyl)imidazole (
108.4 mg, 64%).
9) was obtained
(
0
0
0
D-erythro-N,O,O -Tri-(6 -methoxy-2 -naphthoyl)sphinganine (10). Naphthoyl derivative
8 (1.7 mg, mmol)
was added to a vial containing a suspension of 10% Pd on carbon (0.3 mg) in EtOAc (0.5 mL). The